Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XRCC5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | TPR | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | GNPTG | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | ELOVL1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ZBTB5 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | EIF3L | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | LRRN4CL | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | WDR5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
mRNA | RAB11FIP5 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |